Identification of PRL1 as a novel diagnostic and therapeutic target for castration-resistant prostate cancer by the Escherichia coli ampicillin secretion trap (CAST) method. [electronic resource]
Producer: 20150512Description: 769-78 p. digitalISSN:- 1873-2496
- Aged
- Ampicillin Resistance -- genetics
- Androgen Antagonists -- therapeutic use
- Blotting, Western
- Cell Cycle Proteins -- genetics
- Cell Line, Tumor
- Cell Movement -- genetics
- Cell Proliferation
- Combined Modality Therapy
- ErbB Receptors -- genetics
- Escherichia coli -- genetics
- Gene Expression Regulation, Neoplastic
- Gene Library
- Humans
- Immunohistochemistry
- Male
- Matrix Metalloproteinase 9 -- genetics
- Membrane Proteins -- genetics
- Middle Aged
- Multivariate Analysis
- Prostatectomy -- methods
- Prostatic Neoplasms, Castration-Resistant -- diagnosis
- Protein Tyrosine Phosphatases -- genetics
- RNA Interference
- Reverse Transcriptase Polymerase Chain Reaction
- Signal Transduction -- genetics
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.